RhumbLine Advisers’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-58,251
| Closed | -$883K | – | 2948 |
|
|
2019
Q4 | $883K | Buy |
58,251
+1,342
| +2% | +$11.6K | ﹤0.01% | 2140 |
|
|
2019
Q3 | $364K | Buy |
56,909
+1,629
| +3% | +$13.6K | ﹤0.01% | 2476 |
|
|
2019
Q2 | $528K | Buy |
55,280
+10,008
| +22% | +$108K | ﹤0.01% | 2338 |
|
|
2019
Q1 | $613K | Sell |
45,272
-1,081
| -2% | -$9.01K | ﹤0.01% | 2241 |
|
|
2018
Q4 | $333K | Buy |
46,353
+14,565
| +46% | +$159K | ﹤0.01% | 2484 |
|
|
2018
Q3 | $346K | Sell |
31,788
-2,300
| -7% | -$23.2K | ﹤0.01% | 2449 |
|
|
2018
Q2 | $314K | Sell |
34,088
-2,300
| -6% | -$21.4K | ﹤0.01% | 2506 |
|
|
2018
Q1 | $291K | Sell |
36,388
-1,350
| -4% | -$29.4K | ﹤0.01% | 2449 |
|
|
2017
Q4 | $1.05M | Sell |
37,738
-6,643
| -15% | -$176K | ﹤0.01% | 1922 |
|
|
2017
Q3 | $1.2M | Buy |
44,381
+600
| +1% | +$15.7K | ﹤0.01% | 1887 |
|
|
2017
Q2 | $1.28M | Buy |
43,781
+15,905
| +57% | +$483K | ﹤0.01% | 1822 |
|
|
2017
Q1 | $951K | Buy |
27,876
+1,297
| +5% | +$41.8K | ﹤0.01% | 1949 |
|
|
2016
Q4 | $806K | Buy |
26,579
+2,250
| +9% | +$72.5K | ﹤0.01% | 1970 |
|
|
2016
Q3 | $823K | Buy |
24,329
+4,639
| +24% | +$149K | ﹤0.01% | 1927 |
|
|
2016
Q2 | $576K | Sell |
19,690
-411
| -2% | -$11.3K | ﹤0.01% | 2111 |
|
|
2016
Q1 | $416K | Buy |
20,101
+1,935
| +11% | +$47.5K | ﹤0.01% | 2345 |
|
|
2015
Q4 | $629K | Buy |
18,166
+2,260
| +14% | +$64.9K | ﹤0.01% | 2103 |
|
|
2015
Q3 | $371K | Buy |
15,906
+2,346
| +17% | +$57K | ﹤0.01% | 2419 |
|
|
2015
Q2 | $238K | Buy |
+13,560
| New | +$209K | ﹤0.01% | 2790 |
|
RhumbLine Advisers's DERM Position: Q1 2020 in Review
RhumbLine Advisers sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 58,251 shares — an estimated $883K sold.
RhumbLine Advisers first reported a position in DERM in Q2 2015 and held it in 19 quarters. The position peaked at $1.28M in Q2 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- RhumbLine Advisers reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- RhumbLine Advisers sold 58,251 Dermira, Inc. shares in Q1 2020, an estimated $883K.
- RhumbLine Advisers first reported a position in Dermira, Inc. in Q2 2015 and held it in 19 quarters.
- RhumbLine Advisers's Dermira, Inc. position peaked at $1.28M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.